As the well-known medical journal "Ärzteblatt" reports, the "DGKN" (German Society for Clinical Neurophysiology and Functional Imaging) emphasizes the relevance of VR therapy and argues for its reimbursement by the public health insurance companies.
Further information on this topic you can find in the following articles:
コメント